Meta-analysis of the Effect of Semaglutide on Blood Pressure in Obese Populations
American Journal of Cardiovascular Drugs · 2025-09 · 25 (5) · 655-665
DOI: 10.1007/s40256-025-00738-9 ↗Kurz gefasst
Metaanalyse in der Zeitschrift American Journal of Cardiovascular Drugs, online erschienen am 10.06.2025. Verfasst von Yihan Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Institute of Geriatric Diseases, Hebei General Hospital, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Glucagon-Like Peptides, Blood Pressure, Obesity, Hypertension. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hebei Province, the Medical Science Research Project of Hebei Provincial Health Commission.
Abstract (Originalsprache)
OBJECTIVE: The aim was to systematically evaluate the effect of semaglutide on blood pressure in obese populations using meta-analysis methods. METHODS: Randomized controlled trials on the effect of semaglutide on blood pressure regulation published from the inception of the databases to October 2024 were searched for in PubMed, Embase, the Cochrane Library, and Web of Science. Stata software was used for statistical analysis of the outcome measures in all included studies. Egger's test was applied to assess the risk of publication bias. RESULTS: A total of 22 studies involving 15,347 participants were included in this meta-analysis. The results showed that, compared to the control group, the semaglutide group significantly reduced systolic blood pressure (SBP) (mean difference [MD] - 2.90, 95% confidence interval [CI] - 3.70 to - 2.11; P < 0.01) and diastolic blood pressure (DBP) (MD - 0.86, 95% CI - 1.34 to - 0.38; P < 0.01). Further subgroup analysis revealed that, compared to diabetic populations, semaglutide had a more significant reduction in SBP (- 1.87, 95% CI - 2.67 to - 1.06, vs - 5.02, 95% CI - 6.10 to - 3.94) and DBP (- 0.43, 95% CI - 0.89 to 0.02, vs - 1.96, 95% CI - 3.12 to - 0.80) in non-diabetic populations. The higher dose of semaglutide (2.4 mg) was found to significantly lower SBP (MD - 4.31, 95% CI - 5.18 to - 3.44) and DBP (MD - 1.84, 95% CI - 2.70 to - 0.98), although mild heterogeneity was present. Sensitivity analysis showed that the exclusion of any single study did not significantly affect the final results. CONCLUSION: Current evidence suggests that semaglutide can lower SBP and DBP, and increasing the dosage can enhance the blood pressure-lowering effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Institute of Geriatric Diseases, Hebei General Hospital, Shijiazhuang, Hebei, China.
- Graduate School of Hebei Medical University, Shijiazhuang, Hebei, China.
- General Clinical Laboratory, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
- Department of Pathophysiology, Hebei Medical University, Shijiazhuang, Hebei, China.
- Hebei Key Laboratory of Critical Disease Mechanism and Intervention, Shijiazhuang, Hebei, China.
- The Third General Surgery Department, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hebei Province
- the Medical Science Research Project of Hebei Provincial Health Commission
- Hebei Province Medical Adaptation Technology Tracking Project
- Hebei Province Government-Funded Clinical Medicine Excellent Talent Training Program
Zitieren
APA
Li, Y., Xue, K., Hu, R., Hu, X., Guo, R., Guo, H., & Li, G. (2025). Meta-analysis of the Effect of Semaglutide on Blood Pressure in Obese Populations. American Journal of Cardiovascular Drugs, 25(5), 655-665. https://doi.org/10.1007/s40256-025-00738-9
Vancouver
Li Y, Xue K, Hu R, Hu X, Guo R, Guo H, et al. Meta-analysis of the Effect of Semaglutide on Blood Pressure in Obese Populations. American Journal of Cardiovascular Drugs. 2025;25(5):655-665. doi:10.1007/s40256-025-00738-9
BibTeX
@article{Li2025,
author = {Li, Yihan and Xue, Kefan and Hu, Rui and Hu, Xiao and Guo, Ran and Guo, Hongxia and Li, Gang},
title = {Meta-analysis of the Effect of Semaglutide on Blood Pressure in Obese Populations},
journal = {American Journal of Cardiovascular Drugs},
year = {2025},
volume = {25},
number = {5},
pages = {655--665},
doi = {10.1007/s40256-025-00738-9}
}
EUVIMED